Continued effect of intermittent subcutaneous apomorphine following long-term use in patients with advanced Parkinson's disease

被引：0
|
作者：
Pfeiffer, DF
机构：
来源：
MOVEMENT DISORDERS | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P814
引用
收藏
页码：S281 / S282
页数：2
相关论文
共 50 条
  • [31] Characteristics of good-responders to long-term continuous apomorphine infusions in advanced Parkinson's disease
    Vanderheyden, J-E.
    JOURNAL OF NEUROLOGY, 2008, 255 : 99 - 99
  • [32] Intermittent subcutaneous apomorphine: Evidence for efficacy at early timepoints in Parkinson's disease
    Fernandez, HH
    Van Lunen, BE
    MOVEMENT DISORDERS, 2006, 21 : S110 - S110
  • [33] Subcutaneous Apomorphine and Duodopa Infusion Therapy for Advanced Parkinson's Disease
    Fuchs, G. A.
    Hilker, R.
    Hahne, M.
    Oechsner, M.
    Reichmann, H.
    AKTUELLE NEUROLOGIE, 2011, 38 (10) : 538 - 543
  • [34] Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study
    Borgemeester, Robbert W. K.
    van Lam, Teus
    PARKINSONISM & RELATED DISORDERS, 2017, 45 : 33 - 38
  • [35] A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease
    Chen, JJ
    Obering, C
    CLINICAL THERAPEUTICS, 2005, 27 (11) : 1710 - 1724
  • [36] Long-term update of the effect of spinal cord stimulation in advanced Parkinson's disease patients
    Samotus, Olivia
    Parrent, Andrew
    Jog, Mandar
    BRAIN STIMULATION, 2020, 13 (05) : 1196 - 1197
  • [37] Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease
    Hellmann, Mark A.
    Sabach, Tilda
    Melamed, Eldad
    Djaldetti, Ruth
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (04) : 250 - 252
  • [38] Continuous subcutaneous apomorphine in advanced Parkinson’s disease patients treated with deep brain stimulation
    Ángel Sesar
    Gustavo Fernández-Pajarín
    Begoña Ares
    José-Luis Relova
    Eduardo Arán
    María-Teresa Rivas
    Miguel Gelabert-González
    Alfonso Castro
    Journal of Neurology, 2019, 266 : 659 - 666
  • [39] Continuous subcutaneous apomorphine in advanced Parkinson's disease patients treated with deep brain stimulation
    Sesar, Angel
    Fernandez-Pajarin, Gustavo
    Ares, Begona
    Relova, Jose-Luis
    Aran, Eduardo
    Rivas, Maria-Teresa
    Gelabert-Gonzalez, Miguel
    Castro, Alfonso
    JOURNAL OF NEUROLOGY, 2019, 266 (03) : 659 - 666
  • [40] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
12345